US Patent Issued to Ironshore Pharmaceuticals & Development on Aug. 12 for "Compositions for treatment of attention deficit hyperactivity disorder" (Null, American Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,506, issued on Aug. 12, was assigned to Ironshore Pharmaceuticals & Development Inc. (Camana Bay, Cayman Islands).

"Compositions for treatment of attention deficit hyperactivity disorder" was invented by David Lickrish (Camana Bay, Cayman Islands) and Feng Zhang (Pflugerville, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Therapeutic compositions deliver a therapeutic amount of methylphenidate in a delayed and extended release formulation. The dosage form exhibits a lag time prior to release of from 6 to 8 hours or longer, followed by a sustained release period."

The patent was filed on Jan. 18, 2024, under Application No. 18/416,548.

*For ...